Position in GNLX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$226,806
+$44,457 QoQ
Shares Held
75,351
0.0% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 72 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMG National Trust Bank holds $2,709,733 across 6 Biotechnology names. GNLX ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,956 | $1,219,643 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
17,107 | $587,112 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,617 | $302,831 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
6,369 | $299,597 | |
| 5 | GNLX |
GENELUX Corp
This page
|
75,351 | $226,806 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
43,379 | $73,744 |
All Filings in GNLX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,806 | 75,351 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $182,349 | 75,351 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $328,530 | 75,351 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $316,474 | 75,351 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $216,257 | 75,351 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $203,447 | 75,351 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $177,828 | 75,351 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $178,581 | 75,351 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $146,934 | 75,351 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $323,756 | 50,351 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $705,347 | 50,346 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,232,973 | 50,346 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||